Korro Bio, Inc.(KRRO)

Biotechnology · Cambridge, MA

$9.80-0.18 (-1.76%)

Delayed quote: Oct 6, 2026, 12:49 PM EDT

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T16:52:09.229Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:52:09.229Z.

Quote observation: 2026-10-06T16:49:47.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 97,493,230
TTM free cash flow · period ending 2026-06-30: -68,265,000

FMP input reference: eea6c7d5cd6e3fe508f4e89a8ac0afa25f3437e05bd10ab9ad2dfceb562d4ef8

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

KRRO Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

KRRO Competitors' Price/FCF Ratio

KRRO

Korro Bio, Inc.

Current

Market Cap

$97.49M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNXU

Conexeu Sciences Inc.

vs KRRO

Market Cap

$97.61M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIST

Milestone Pharmaceuticals Inc.

vs KRRO

Market Cap

$96.75M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PYPD

PolyPid Ltd.

vs KRRO

Market Cap

$99.61M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BMEA

Biomea Fusion, Inc.

vs KRRO

Market Cap

$93.63M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PARK

Park Dental Partners, Inc. Common Stock

vs KRRO

Market Cap

$93.26M

Price/FCF Ratio

0.02

TTM Avg

3.14

3Y Avg

3.14

5Y Avg

3.14

OKUR

OnKure Therapeutics, Inc.

vs KRRO

Market Cap

$102.25M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JYNT

The Joint Corp.

vs KRRO

Market Cap

$102.51M

Price/FCF Ratio

24.24

TTM Avg

107.29

3Y Avg

57.88

5Y Avg

61.33

PLYX

Polaryx Therapeutics, Inc. Common Stock

vs KRRO

Market Cap

$103.68M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Equillium, Inc.

vs KRRO

Market Cap

$90.73M

Price/FCF Ratio

N/A

TTM Avg

24.77

3Y Avg

24.77

5Y Avg

24.77

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Korro Bio, Inc. (KRRO)	$97.49M	N/A	N/A	N/A	N/A
Conexeu Sciences Inc. (CNXU)vs ›	$97.61M	N/A	N/A	N/A	N/A
Milestone Pharmaceuticals Inc. (MIST)vs ›	$96.75M	N/A	N/A	N/A	N/A
PolyPid Ltd. (PYPD)vs ›	$99.61M	N/A	N/A	N/A	N/A
Biomea Fusion, Inc. (BMEA)vs ›	$93.63M	N/A	N/A	N/A	N/A
Park Dental Partners, Inc. Common Stock (PARK)vs ›	$93.26M	0.02	3.14	3.14	3.14
OnKure Therapeutics, Inc. (OKUR)vs ›	$102.25M	N/A	N/A	N/A	N/A
The Joint Corp. (JYNT)vs ›	$102.51M	24.24	107.29	57.88	61.33
Polaryx Therapeutics, Inc. Common Stock (PLYX)vs ›	$103.68M	N/A	N/A	N/A	N/A
Equillium, Inc. (EQ)vs ›	$90.73M	N/A	24.77	24.77	24.77

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio: N/A

KRRO Price/FCF Ratio Metrics

KRRO Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics